Victoria Jacobs

1.5k total citations
41 papers, 969 citations indexed

About

Victoria Jacobs is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Victoria Jacobs has authored 41 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 7 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Victoria Jacobs's work include Atrial Fibrillation Management and Outcomes (30 papers), Cardiac Arrhythmias and Treatments (14 papers) and Acute Ischemic Stroke Management (7 papers). Victoria Jacobs is often cited by papers focused on Atrial Fibrillation Management and Outcomes (30 papers), Cardiac Arrhythmias and Treatments (14 papers) and Acute Ischemic Stroke Management (7 papers). Victoria Jacobs collaborates with scholars based in United States, Belgium and Australia. Victoria Jacobs's co-authors include T. Jared Bunch, John Day, Michael J. Cutler, Heidi T. May, Brian G. Crandall, Jeffrey S. Osborn, Tami L. Bair, J. Peter Weiss, Charles Mallender and Jeffrey L. Anderson and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Victoria Jacobs

41 papers receiving 944 citations

Peers

Countries citing papers authored by Victoria Jacobs

Since Specialization

Citations

This map shows the geographic impact of Victoria Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Jacobs more than expected).

Fields of papers citing papers by Victoria Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Jacobs. The network helps show where Victoria Jacobs may publish in the future.

Co-authorship network of co-authors of Victoria Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Jacobs. A scholar is included among the top collaborators of Victoria Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Jacobs. Victoria Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphocyte Activation Gene 3 Expression, γδ T-Cell/Major Histocompatibility Complex Class I Interactions, and Prognosis in Merkel Cell Carcinoma 2024 ·Laboratory Investigation ·(unknown), (unknown), (unknown), Ludmila Danilova, Long Yuan, Victoria Jacobs, Aleksandra Ogurtsova, Elizabeth L. Engle, Joel Sunshine	1
2	IMPACT OF ANTICOAGULATION THERAPY ON THECOGNITIVE DECLINE AND DEMENTIA IN PATIENTS WITH NON-VALVULARATRIALFIBRILLATION (CAF) TRIAL 2022 ·Journal of the American College of Cardiology ·T. Jared Bunch, Heidi T. May, Michael J. Cutler, Scott C. Woller, Victoria Jacobs, Scott M. Stevens, John F. Carlquist, Kirk U. Knowlton, Joseph B. Muhlestein, Benjamin A. Steinberg, Jeffrey L. Anderson	2
3	Discovery of TITIN Gene Truncating Variant Mutations and 5-Year Outcomes in Patients With Nonischemic Dilated Cardiomyopathy 2020 ·The American Journal of Cardiology ·Jeffrey L. Anderson, G. Bryce Christensen, (unknown), Benjamin D. Horne, Stacey Knight, Victoria Jacobs, K. Afshar, Virginia B. Hebl, Joseph B. Muhlestein, Kirk U. Knowlton, John F. Carlquist, Lincoln Nadauld	9
4	Biomarkers in the risk assessment for stroke and dementia in atrial fibrillation 2019 ·Current Opinion in Cardiology ·(unknown), Victoria Jacobs, T. Jared Bunch	5
5	CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation 2019 ·Heart Rhythm ·(unknown), Heidi T. May, Victoria Jacobs, Kirk U. Knowlton, Joseph B Muhlestein, Donald Lappé, Jeffrey L. Anderson, Benjamin D. Horne, T. Jared Bunch	15
6	The role of microRNAs in the development, regulation, and treatment of atrial fibrillation 2019 ·Journal of Interventional Cardiac Electrophysiology ·(unknown), Victoria Jacobs, Stacey Knight, (unknown), Michael J. Cutler, Joseph B. Muhlestein, (unknown), Kirk U. Knowlton, T. Jared Bunch	18
7	Circulating Levels of Biomarkers of Cerebral Injury in Patients with Atrial Fibrillation 2019 ·The American Journal of Cardiology ·(unknown), Victoria Jacobs, Stacey Knight, Daniel Bride, Michael J. Cutler, Joseph B. Muhlestein, (unknown), Jeffrey L. Anderson, Kirk U. Knowlton, T. Jared Bunch	14
8	Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes 2019 ·Arrhythmia & Electrophysiology Review ·T. Jared Bunch, (unknown), (unknown), Victoria Jacobs, Heidi T. May	25
9	Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease 2019 ·Heart Rhythm ·T. Jared Bunch, Tami L. Bair, Brian G. Crandall, Michael J. Cutler, John Day, (unknown), Victoria Jacobs, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, Heidi T. May	24
10	Atrial Fibrillation Ablation and its Impact on Stroke 2018 ·Current Treatment Options in Cardiovascular Medicine ·(unknown), Victoria Jacobs, Heidi T. May, Michael J. Cutler, John Day, T. Jared Bunch	5
11	The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia 2018 ·The American Journal of Cardiology ·(unknown), Heidi T. May, Tami L. Bair, Victoria Jacobs, Brian G. Crandall, Michael J. Cutler, John Day, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch	7
12	The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation 2017 ·The American Journal of Cardiology ·(unknown), Heidi T. May, Tami L. Bair, Victoria Jacobs, Brian G. Crandall, Michael J. Cutler, John Day, Charles Mallender, Jeffrey S. Osborn, Scott M. Stevens, J. Peter Weiss, Scott C. Woller, T. Jared Bunch	4
13	Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin 2017 ·American Heart Journal ·(unknown), Heidi T. May, Victoria Jacobs, Tami L. Bair, Scott M. Stevens, Scott C. Woller, Brian G. Crandall, Michael J. Cutler, John Day, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch	35
14	Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation 2016 ·Journal of Interventional Cardiac Electrophysiology ·T. Jared Bunch, Heidi T. May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler, Victoria Jacobs, Charles Mallender, Joseph B. Muhlestein, Jeffrey S. Osborn, J. Peter Weiss, John Day	27
15	Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation 2016 ·The American Journal of Cardiology ·Victoria Jacobs, Heidi T. May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler, John Day, Charles Mallender, Jeffrey S. Osborn, Scott M. Stevens, J. Peter Weiss, Scott C. Woller, T. Jared Bunch	111
16	Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications 2016 ·Journal of the American Heart Association ·T. Jared Bunch, Heidi T. May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler, John Day, Victoria Jacobs, Charles Mallender, Jeffrey S. Osborn, Scott M. Stevens, J. Peter Weiss, Scott C. Woller	35
17	Abstract 11938: Long-term Population-based Outcomes of Novel Oral Anticoagulants Compared to Warfarin Among Long-term Anticoagulated Patients: A Propensity Matched Analysis 2015 ·Circulation ·Victoria Jacobs, Heidi T. May, Tami L. Bair, Jeffrey L. Anderson, Brian G. Crandall, Michael J. Cutler, John Day, Charles Mallender, Jeffrey S. Osborn, Scott M. Stevens, J. Peter Weiss, Scott C. Woller, T. Jared Bunch	1
18	Atrial fibrillation and dementia 2014 ·Trends in Cardiovascular Medicine ·Victoria Jacobs, Michael J. Cutler, John Day, T. Jared Bunch	58
19	Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia 2014 ·Heart Rhythm ·Victoria Jacobs, Scott C. Woller, Scott M. Stevens, Heidi T. May, Tami L. Bair, Jeffrey L. Anderson, Brian G. Crandall, John Day, (unknown), (unknown), Charles Mallender, Jeffrey L. Olson, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch	118
20	Depressed Phagocytosis in Hemodialyzed Patients: In vivo and in vitro Mechanisms 1993 ·The Nephron journals/Nephron journals ·R. Vanholder, Roberto Dell’Aquila, Victoria Jacobs, Annemieke Dhondt, Nic Veys, (unknown), N. Van Landschoot, Wim Van Biesen, S Ringoir	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact